Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion

A V Krylatov, D S Ugdyshekova, N A Bernatskaya, L N Maslov, R Mekhoulam, R G Pertwee, G B Stephano

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Preliminary intravenous injection of cannabinoid receptor agonist HU-210 (0.05 mg/kg) reduced the incidence of ventricular arrhythmias during 10-min coronary occlusion and 10-min reperfusion in chloralose-anesthetized rats. Preliminary injection of type I cannabinoid receptor antagonist SR 141716A (3 mg/kg) had no effect on the antiarrhythmic effect of HU-210, while type II cannabinoid receptor antagonist SR 144528 (1 mg/kg) completely abolished the effect of HU-210. Preconditioning with glibenclamide (0.3 mg/kg), an inhibitor of ATP-dependent K+-channels, did not affect the antiarrhythmic activity of HU-210. These findings suggest that antiarrhythmic effect of HU-210 is mediated through activation of type II cannabinoid receptors rather than activation of K+-channels.

Original languageEnglish
Pages (from-to)523-525
Number of pages3
JournalBulletin of Experimental Biology and Medicine
Volume131
Publication statusPublished - 2001

Keywords

  • arrhythmias
  • cannabinoid receptors
  • K+ channels
  • VENTRICULAR ARRHYTHMIAS
  • ISCHEMIA
  • PHARMACOLOGY
  • INFARCTION
  • MECHANISMS
  • RATS

Cite this

Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. / Krylatov, A V ; Ugdyshekova, D S ; Bernatskaya, N A ; Maslov, L N ; Mekhoulam, R ; Pertwee, R G ; Stephano, G B .

In: Bulletin of Experimental Biology and Medicine, Vol. 131, 2001, p. 523-525.

Research output: Contribution to journalArticle

Krylatov, A V ; Ugdyshekova, D S ; Bernatskaya, N A ; Maslov, L N ; Mekhoulam, R ; Pertwee, R G ; Stephano, G B . / Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. In: Bulletin of Experimental Biology and Medicine. 2001 ; Vol. 131. pp. 523-525.
@article{28cf6f46f0ac43cba823b0bfed56acfa,
title = "Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion",
abstract = "Preliminary intravenous injection of cannabinoid receptor agonist HU-210 (0.05 mg/kg) reduced the incidence of ventricular arrhythmias during 10-min coronary occlusion and 10-min reperfusion in chloralose-anesthetized rats. Preliminary injection of type I cannabinoid receptor antagonist SR 141716A (3 mg/kg) had no effect on the antiarrhythmic effect of HU-210, while type II cannabinoid receptor antagonist SR 144528 (1 mg/kg) completely abolished the effect of HU-210. Preconditioning with glibenclamide (0.3 mg/kg), an inhibitor of ATP-dependent K+-channels, did not affect the antiarrhythmic activity of HU-210. These findings suggest that antiarrhythmic effect of HU-210 is mediated through activation of type II cannabinoid receptors rather than activation of K+-channels.",
keywords = "arrhythmias, cannabinoid receptors, K+ channels, VENTRICULAR ARRHYTHMIAS, ISCHEMIA, PHARMACOLOGY, INFARCTION, MECHANISMS, RATS",
author = "Krylatov, {A V} and Ugdyshekova, {D S} and Bernatskaya, {N A} and Maslov, {L N} and R Mekhoulam and Pertwee, {R G} and Stephano, {G B}",
year = "2001",
language = "English",
volume = "131",
pages = "523--525",
journal = "Bulletin of Experimental Biology and Medicine",
issn = "0007-4888",
publisher = "Springer New York",

}

TY - JOUR

T1 - Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion

AU - Krylatov, A V

AU - Ugdyshekova, D S

AU - Bernatskaya, N A

AU - Maslov, L N

AU - Mekhoulam, R

AU - Pertwee, R G

AU - Stephano, G B

PY - 2001

Y1 - 2001

N2 - Preliminary intravenous injection of cannabinoid receptor agonist HU-210 (0.05 mg/kg) reduced the incidence of ventricular arrhythmias during 10-min coronary occlusion and 10-min reperfusion in chloralose-anesthetized rats. Preliminary injection of type I cannabinoid receptor antagonist SR 141716A (3 mg/kg) had no effect on the antiarrhythmic effect of HU-210, while type II cannabinoid receptor antagonist SR 144528 (1 mg/kg) completely abolished the effect of HU-210. Preconditioning with glibenclamide (0.3 mg/kg), an inhibitor of ATP-dependent K+-channels, did not affect the antiarrhythmic activity of HU-210. These findings suggest that antiarrhythmic effect of HU-210 is mediated through activation of type II cannabinoid receptors rather than activation of K+-channels.

AB - Preliminary intravenous injection of cannabinoid receptor agonist HU-210 (0.05 mg/kg) reduced the incidence of ventricular arrhythmias during 10-min coronary occlusion and 10-min reperfusion in chloralose-anesthetized rats. Preliminary injection of type I cannabinoid receptor antagonist SR 141716A (3 mg/kg) had no effect on the antiarrhythmic effect of HU-210, while type II cannabinoid receptor antagonist SR 144528 (1 mg/kg) completely abolished the effect of HU-210. Preconditioning with glibenclamide (0.3 mg/kg), an inhibitor of ATP-dependent K+-channels, did not affect the antiarrhythmic activity of HU-210. These findings suggest that antiarrhythmic effect of HU-210 is mediated through activation of type II cannabinoid receptors rather than activation of K+-channels.

KW - arrhythmias

KW - cannabinoid receptors

KW - K+ channels

KW - VENTRICULAR ARRHYTHMIAS

KW - ISCHEMIA

KW - PHARMACOLOGY

KW - INFARCTION

KW - MECHANISMS

KW - RATS

M3 - Article

VL - 131

SP - 523

EP - 525

JO - Bulletin of Experimental Biology and Medicine

JF - Bulletin of Experimental Biology and Medicine

SN - 0007-4888

ER -